Cite
Keith JM, Jones WM, Tichenor M, et al. Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Med Chem Lett. 2015;6(12):1204-8doi: 10.1021/acsmedchemlett.5b00353.
Keith, J. M., Jones, W. M., Tichenor, M., Liu, J., Seierstad, M., Palmer, J. A., Webb, M., Karbarz, M., Scott, B. P., Wilson, S. J., Luo, L., Wennerholm, M. L., Chang, L., Rizzolio, M., Rynberg, R., Chaplan, S. R., & Breitenbucher, J. G. (2015). Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS medicinal chemistry letters, 6(12), 1204-8. https://doi.org/10.1021/acsmedchemlett.5b00353
Keith, John M, et al. "Preclinical Characterization of the FAAH Inhibitor JNJ-42165279." ACS medicinal chemistry letters vol. 6,12 (2015): 1204-8. doi: https://doi.org/10.1021/acsmedchemlett.5b00353
Keith JM, Jones WM, Tichenor M, Liu J, Seierstad M, Palmer JA, Webb M, Karbarz M, Scott BP, Wilson SJ, Luo L, Wennerholm ML, Chang L, Rizzolio M, Rynberg R, Chaplan SR, Breitenbucher JG. Preclinical Characterization of the FAAH Inhibitor JNJ-42165279. ACS Med Chem Lett. 2015 Nov 02;6(12):1204-8. doi: 10.1021/acsmedchemlett.5b00353. eCollection 2015 Dec 10. PMID: 26713105; PMCID: PMC4677372.
Copy
Download .nbib